Holt Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $880K | Hold |
1,977
| – | – | 0.15% | 85 |
|
|
2025
Q1 | $958K | Buy |
1,977
+9
| +0.5% | +$4.36K | 0.15% | 92 |
|
|
2024
Q4 | $793K | Sell |
1,968
-5
| -0.3% | -$2.01K | 0.12% | 101 |
|
|
2024
Q3 | $918K | Buy |
1,973
+148
| +8% | +$68.8K | 0.14% | 94 |
|
|
2024
Q2 | $855K | Hold |
1,825
| – | – | 0.18% | 78 |
|
|
2024
Q1 | $763K | Buy |
1,825
+665
| +57% | +$278K | 0.13% | 100 |
|
|
2023
Q4 | $472K | Buy |
+1,160
| New | +$472K | 0.08% | 117 |
|
|
2020
Q4 | – | Sell |
-1,500
| Closed | -$408K | – | 158 |
|
|
2020
Q3 | $408K | Hold |
1,500
| – | – | 0.11% | 105 |
|
|
2020
Q2 | $435K | Hold |
1,500
| – | – | 0.12% | 102 |
|
|
2020
Q1 | $357K | Hold |
1,500
| – | – | 0.12% | 100 |
|
|
2019
Q4 | $328K | Buy |
+1,500
| New | +$328K | 0.08% | 122 |
|